Harrow (HROW) Change in Accured Expenses (2010 - 2026)
Harrow (HROW) recorded quarterly Change in Accured Expenses of -$1.2 million in Q1 2026, down 231.4% quarter-over-quarter from $914000.0 in Q4 2025, and up 36.49% on a YoY basis from -$879926.8 in Q1 2025.
Harrow (HROW) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Harrow's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$1.2 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 36.49% year-over-year to -$1.2 million; the TTM figure through Mar 2026 stood at $1.6 million (down 36.93% YoY), while the FY2025 annual figure was $936000.0, down 76.87% from the prior year.
- Change in Accured Expenses was -$1.2 million for Q1 2026 at Harrow, down from $914000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $24.0 million in Q3 2025 to a low of -$22.1 million in Q2 2025.
- Historically, Change in Accured Expenses has averaged $361294.1 across 5 years, with a median of $342000.0 in 2023.
- Biggest YoY gain for Change in Accured Expenses was 1006.43% in 2024; the steepest drop was 1922.14% in 2024.
- A 5-year view of Change in Accured Expenses shows it stood at $584000.0 in 2022, then plunged by 77.57% to $131000.0 in 2023, then sank by 1922.14% to -$2.4 million in 2024, then surged by 138.29% to $914000.0 in 2025, then plunged by 231.4% to -$1.2 million in 2026.
- The last three Change in Accured Expenses figures came in at -$1.2 million (Q1 2026), $914000.0 (Q4 2025), and $24.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 10.02 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 23.00 Mn |
| 10 | Harrow | 1.25 Bn | 1.15 Bn | 27.05 Mn | -1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.20 Mn |
| Mar 31, 2026 | -1.20 Mn |
| Dec 31, 2025 | 914,000.00 |
| Dec 31, 2025 | 914,000.00 |
| Sep 30, 2025 | 24.03 Mn |
| Sep 30, 2025 | 24.03 Mn |
| Jun 30, 2025 | -22.12 Mn |
| Jun 30, 2025 | -22.12 Mn |
| Mar 31, 2025 | -1.89 Mn |
| Mar 31, 2025 | -1.89 Mn |
| Dec 31, 2024 | -2.39 Mn |
| Dec 31, 2024 | -2.39 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 3.78 Mn |
| Jun 30, 2024 | 3.78 Mn |
| Mar 31, 2024 | -423,000.00 |
| Mar 31, 2024 | -423,000.00 |
| Dec 31, 2023 | 131,000.00 |
| Dec 31, 2023 | 131,000.00 |